| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|---|---|---|---|---|---|---|---|---|
| (m) | (m) | (m) | (m) | (m) | $49.35 | (m) | (m) | (m) | (m) |
| Date | Stock | Analyst | Firm | Price When Rated | Price Target | Upside / Downside | Rating | Performance |
|---|---|---|---|---|---|---|---|---|
| 2026-09-07 | GSK GSK plc | James Gordon | Barclays | $18.67 | $18.00 | -3.59% | Underweight | |
| 2026-06-28 | GSK GSK plc | James Gordon | Barclays | $19.83 | $19.00 | -4.19% | Underweight | |
| 2026-04-29 | GSK GSK plc | James Gordon | Barclays | $19.18 | $18.00 | -6.15% | Underweight | |
| 2026-02-19 | GSK GSK plc | James Gordon | Barclays | $22.13 | $19.00 | -14.14% | Underweight | |
| 2026-01-06 | GSK GSK plc | James Gordon | Barclays | $19.00 | $17.80 | -6.32% | Underweight | |
| 2024-11-07 | GSK GSK plc | James Gordon | Barclays | $13.80 | $14.50 | +5.07% | Equal Weight | |
| 2024-09-30 | GSK GSK plc | James Gordon | Barclays | $15.17 | $15.50 | +2.18% | Equal Weight | |
| 2024-08-04 | GSK GSK plc | James Gordon | Barclays | $15.63 | $16.50 | +5.57% | Equal Weight | |
| 2024-04-07 | GSK GSK plc | James Gordon | Barclays | $16.20 | $17.25 | +6.48% | Equal Weight |